Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Kenvue Inc. (KVUE : NYSE)

• Company Description    Kenvue Inc. is a pure-play consumer health company. Its brand portfolio includes AVEENO(R), BAND-AID(R) Brand Adhesive Bandages, JOHNSON'S(R), LISTERINE(R), NEUTROGENA(R), TYLENOL(R) and ZYRTEC(R). Kenvue Inc. is based in SKILLMAN, N.J. Number of Employees: 22,000

• Price / Volume Information    Yesterday's Closing Price: $21.05 Daily Weekly Monthly 20 Day Moving Average: 17,396,788 shares Shares Outstanding: 1,918.69 (millions) Market Capitalization: $40,388.45 (millions) Beta: 0.83 52 Week High: $25.17 52 Week Low: $17.67 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -3.13% -7.43% 12 Week -4.71% -18.61% Year To Date -1.41% -7.65%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1 KENVUE WAY - SUMMIT,NJ 07901 USA ph: 908-874-1200 fax: - kenvue_ir@kenvue.com http://www.kenvue.com

• General Corporate Information    Officers Thibaut Mongon - Chief Executive Officer and Director Larry J. Merlo - Chair of the Board Paul Ruh - Chief Financial Officer Richard E. Allison - Director Tamara S. Franklin - Director Peer Information Kenvue Inc. (EPC) Kenvue Inc. (HPPS) Kenvue Inc. (ADRNY) Kenvue Inc. (YHGJ) Kenvue Inc. (GPSYY) Kenvue Inc. (HENKY) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: CONS PD- MISC STPL Sector: Consumer Staples CUSIP: 49177J102 SIC: 2844 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/05/25 Share - Related Items Shares Outstanding: 1,918.69 Most Recent Split Date: (:1) Beta: 0.83 Market Capitalization: $40,388.45 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 3.90% Current Fiscal Quarter EPS Consensus Estimate: $0.32 Indicated Annual Dividend: $0.82 Current Fiscal Year EPS Consensus Estimate: $1.12 Payout Ratio: 0.75 Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 5.76% Last Dividend Paid: 05/14/2025 - $0.20 Next EPS Report Date: 08/05/25

• Fundamental Ratios P/E Current FY Estimate: 18.85 Trailing 12 Months: 19.14 PEG Ratio: 3.27 Price Ratios Price/Book: 4.02 Price/Cash Flow: 14.31 Price / Sales: 2.64 EPS Growth vs. Year Ago Period: -14.29% vs. Previous Quarter: -7.69% Sales Growth vs. Year Ago Period: -3.93% vs. Previous Quarter: 2.16% ROE 06/30/25 - - 03/31/25 - 20.87 12/31/24 - 21.38 ROA 06/30/25 - - 03/31/25 - 8.04 12/31/24 - 8.27 Current Ratio 06/30/25 - - 03/31/25 - 0.86 12/31/24 - 0.96 Quick Ratio 06/30/25 - - 03/31/25 - 0.60 12/31/24 - 0.69 Operating Margin 06/30/25 - - 03/31/25 - 13.83 12/31/24 - 14.22 Net Margin 06/30/25 - - 03/31/25 - 6.90 12/31/24 - 6.66 Pre-Tax Margin 06/30/25 - - 03/31/25 - 9.45 12/31/24 - 9.16 Book Value 06/30/25 - - 03/31/25 - 5.24 12/31/24 - 5.04 Inventory Turnover 06/30/25 - - 03/31/25 - 3.70 12/31/24 - 3.64 Debt-to-Equity 06/30/25 - - 03/31/25 - 0.63 12/31/24 - 0.73 Debt-to-Capital 06/30/25 - - 03/31/25 - 38.56 12/31/24 - 42.19

Powered by Zacks Investment Research ©